Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital LP | 4,000,000 7.810% | 143,537 (+3.72%) | Filing History |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital LP | 1,900,000 5.910% | 100,000 (+5.56%) | Filing History |
| 2022-02-14 08:55 am Purchase | 2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Deep Track Capital LP | 250,000 6.270% | 50,510 (+25.32%) | Filing History |
| 2022-02-11 5:11 pm Purchase | 2022-02-04 | 13G | Immunovant, Inc. IMVT | Deep Track Capital LP | 6,780,827 5.830% | 6,780,827 (New Position) | Filing History |
| 2022-02-03 9:43 pm Purchase | 2022-01-28 | 13G | Kura Oncology, Inc. KURA | Deep Track Capital LP | 3,362,000 5.050% | 3,362,000 (New Position) | Filing History |
| 2022-01-27 4:35 pm Purchase | 2022-01-24 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital LP | 1,496,138 5.090% | 1,496,138 (New Position) | Filing History |
| 2022-01-27 4:34 pm Purchase | 2022-01-24 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Deep Track Capital LP | 2,414,917 5.970% | 2,414,917 (New Position) | Filing History |
| 2022-01-20 4:27 pm Purchase | 2022-01-18 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 2,816,950 5.470% | 2,816,950 (New Position) | Filing History |
| 2021-12-30 4:37 pm Purchase | 2021-12-29 | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital LP | 1,288,724 5.450% | 1,288,724 (New Position) | Filing History |
| 2021-12-09 4:54 pm Purchase | 2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR | Deep Track Capital LP | 6,345,790 9.990% | 6,345,790 (New Position) | Filing History |
| 2021-11-17 4:11 pm Purchase | 2021-11-15 | 13G | TRICIDA INC TCDAQ | Deep Track Capital LP | 5,857,829 9.990% | 5,857,829 (New Position) | Filing History |
| 2021-11-04 5:02 pm Purchase | 2021-10-29 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital LP | 1,800,000 5.690% | 1,800,000 (New Position) | Filing History |
| 2021-10-29 4:33 pm Purchase | 2021-10-28 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital LP | 2,104,600 5.120% | 2,104,600 (New Position) | Filing History |
| 2021-10-25 5:16 pm Purchase | 2021-10-21 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital LP | 1,266,884 5.180% | 1,266,884 (New Position) | Filing History |
| 2021-10-25 5:12 pm Purchase | 2021-10-22 | 13G | Passage Bio, Inc. PASG | Deep Track Capital LP | 142,647 5.270% | 142,647 (New Position) | Filing History |
| 2021-10-12 4:55 pm Purchase | 2021-10-08 | 13G | Assembly Biosciences, Inc. ASMB | Deep Track Capital LP | 199,490 5.320% | 199,490 (New Position) | Filing History |
| 2021-09-24 5:01 pm Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital LP | 1,819,689 9.900% | 1,819,689 (New Position) | Filing History |
| 2021-09-01 4:20 pm Purchase | 2021-08-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital LP | 3,856,463 7.530% | 3,856,463 (New Position) | Filing History |
| 2021-08-13 4:27 pm Purchase | 2021-08-04 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 3,090,200 5.090% | 3,090,200 (New Position) | Filing History |
| 2021-08-05 5:10 pm Purchase | 2021-07-30 | 13G | AVROBIO, Inc. AVRO | Deep Track Capital LP | 184,261 5.070% | 184,261 (New Position) | Filing History |